Aura Biosciences, Inc. logo AURA - Aura Biosciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $17.50 DETAILS
HIGH: $18.00
LOW: $17.00
MEDIAN: $17.50
CONSENSUS: $17.50
UPSIDE: 136.49%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0.3 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 (0.3) 0 0 0 0 (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 30.7 28.0 21.9 22.2 22.9 23.3 22.3 17.0 16.9 17.1 20.3 15.4 15.1 14.4 13.2 11.3 9.5 8.3 8.0 6.4 6.6 4.2 3.5 2.9 5.3 6.3
SG&A Expenses 17.3 6.9 5.3 5.7 5.7 5.7 5.5 6.2 5.9 5.0 4.5 5.1 5.2 5.0 4.5 4.8 4.3 4.5 3.6 2.5 2.2 1.7 1.4 0.8 0.8 1.2
Other Expenses 0 0 0 0 (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 48.1 34.9 27.2 27.9 28.3 29.0 27.8 23.2 22.8 22.0 24.8 20.5 20.3 19.4 17.6 16.1 13.8 12.8 11.6 8.9 8.8 5.9 4.9 3.6 6.2 7.5
Operating Income
Operating Income (48.1) (34.9) (27.2) (27.9) (28.6) (29.0) (27.8) (23.2) (22.8) (22.3) (24.8) (20.5) (20.3) (19.4) (17.6) (16.1) (13.8) (12.8) (11.6) (8.9) (8.8) (5.9) (4.9) (3.6) (6.2) (7.5)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0 0
Interest Income 2.5 1.2 1.5 1.8 1.7 1.6 2.0 2.3 2.5 2.7 2.6 2.0 2.0 2.0 1.1 0.5 0.3 0.0 0.0 0.0 0.0 0 0 0 0.0 0.0
Profitability
EBITDA (48.1) (32.5) (25.3) (25.8) (26.7) (27.2) (27.5) (20.7) (20.0) (19.4) (21.7) (18.2) (18.0) (17.1) (16.2) (15.6) (13.2) (12.6) (11.4) (8.6) (8.7) (5.7) (4.7) (3.4) (6.0) (7.3)
EBIT (48.1) (33.7) (25.5) (26.1) (27.0) (27.5) (27.8) (21.0) (20.3) (19.7) (22.0) (18.5) (18.3) (17.5) (16.6) (15.9) (13.5) (12.8) (11.6) (8.8) (8.9) (5.9) (4.9) (3.6) (6.2) (7.5)
Income Before Tax (45.6) (33.7) (25.5) (26.1) (27.0) (27.5) (25.8) (21.0) (20.3) (19.7) (22.0) (18.5) (18.3) (17.5) (16.6) (15.9) (13.5) (12.8) (11.6) (8.8) (8.9) (5.9) (4.9) (3.6) (6.2) (7.5)
Income Tax Expense 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (45.6) (33.7) (25.6) (26.1) (27.0) (27.5) (25.8) (21.0) (20.3) (19.7) (22.1) (18.5) (18.3) (17.5) (16.6) (15.9) (13.5) (12.8) (11.6) (8.8) (8.9) (5.9) (4.9) (3.6) (8.1) (9.4)
Per Share Data
EPS (Basic) -0.48 -0.50 -0.40 -0.40 -0.47 -0.55 -0.52 -0.42 -0.41 -0.40 -0.50 -0.48 -0.48 -0.40 -1.31 -0.54 -0.46 -0.44 -0.42 -0.32 -0.45 -0.30 -0.25 -0.19 -0.22 -0.27
EPS (Diluted) -0.48 -0.50 -0.40 -0.40 -0.47 -0.55 -0.52 -0.42 -0.41 -0.40 -0.50 -0.48 -0.48 -0.40 -1.31 -0.54 -0.46 -0.44 -0.42 -0.32 -0.45 -0.30 -0.25 -0.19 -0.22 -0.27
Shares Outstanding 94.9 67.4 60.3 65.9 58.0 50.1 49.7 49.7 49.5 49.5 44.4 38.2 37.9 37.8 31.9 29.3 29.3 29.2 28.0 28.0 19.6 19.6 19.6 19.6 36.5 34.6
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 67.8 84.8 59.5 47.6 107.4 38.2 31.7 25.4 30.1 26.3 41.1 55.6 47.7 38.5 121.6 61.1 53.8 108.4 149.1 81.8 92.2 99.7 17.4
Short-Term Investments 256.0 29.9 84.7 114.3 69.9 89.8 119.4 149.0 157.3 176.6 185.1 93.5 114.3 135.0 67.2 50.4 68.3 24.9 0 0 0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 1.1 1.2 6.1 2.6 1.8 1.8 3.4 7.5 2.3 3.8 4.5 3.3 4.1 5.7 4.0 4.5 4.4 0.1 0.1 0.6 0.0 0.0
Total Current Assets 329.0 118.5 149.7 170.1 184.0 134.5 160.6 183.5 195.6 212.2 231.8 153.9 166.2 179.1 196.7 115.9 127.7 139.6 153.7 83.5 92.9 100.7 18.5
Non-Current Assets
Property, Plant & Equipment 17.2 17.9 18.5 18.9 19.5 20.1 20.6 21.1 21.5 21.6 22.0 24.4 25.1 25.5 26.0 26.5 6.5 6.7 6.2 5.5 5.3 4.3 3.6
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0.8 0 0 0.8 0 0.8 0 0 0 0 0.8 0 0 0 0 0 0.1 0.1 0
Other Non-Current Assets 1.9 1.3 1.2 1.0 0.2 0.8 1.3 0.0 1.2 0.5 1.3 1.5 1.5 1.4 0.4 0.8 0.9 0.1 0.1 1.7 0.3 0 0.1
Total Non-Current Assets 19.1 19.2 19.7 19.9 20.4 20.9 21.9 21.9 22.7 22.8 23.3 25.9 26.5 26.9 27.2 27.2 7.4 6.8 6.3 7.2 5.8 4.4 3.6
Total Assets 348.1 137.7 169.4 190.0 204.4 155.4 182.5 205.3 218.3 235.0 255.1 179.8 192.7 206.0 223.9 143.1 135.0 146.4 160.0 90.7 98.7 105.1 22.1
Current Liabilities
Account Payables 2.3 2.6 1.5 1.9 1.3 2.0 2.3 2.0 1.5 1.9 1.8 1.5 0.6 1.1 2.9 1.7 1.2 2.0 2.4 1.7 2.4 1.3 0.6
Short-Term Debt 0 0 0 0 0 0 0 0 0 2.7 0 0 0 0 0 0 0 0 0 0 0 0.4 0.0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 0 3.0 6.2 0.2 4.6 3.2 0.6 5.4 0.8 3.2 0.9 1.0 0.8 0.5 3.0 0.5 0.5 0.2 2.7 2.3 0.4 1.3 1.3
Total Current Liabilities 19.6 16.7 18.4 18.8 14.9 12.2 14.9 14.7 10.5 9.7 12.4 10.9 8.9 8.1 10.5 10.0 5.8 5.0 7.4 5.8 5.3 3.4 2.7
Non-Current Liabilities
Long-Term Debt 0 13.7 14.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.1 0 16.6 0.1 0.1 0.1
Total Non-Current Liabilities 13.3 13.7 14.1 14.5 14.9 15.3 15.6 16.0 16.3 16.6 16.9 17.2 17.4 17.7 17.9 18.1 0.1 0.3 0.4 17.2 0.8 0.6 0.1
Total Liabilities 32.9 30.4 32.5 33.4 29.8 27.4 30.5 30.7 26.8 26.2 29.2 28.0 26.3 25.8 28.4 28.1 5.9 5.3 7.7 23.0 6.1 4.0 2.7
Stockholders' Equity
Common Stock 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Retained Earnings (559.7) (514.1) (480.4) (454.9) (428.7) (401.7) (374.2) (348.4) (327.4) (307.0) (287.3) (265.2) (246.7) (228.4) (210.9) (194.3) (178.4) (165.0) (152.1) (140.5) (131.7) (122.8) (116.9)
Accumulated Other Comprehensive Income (0.7) (0.2) (0.1) 0.1 0.0 0.1 0.3 0.6 (0.2) 0.0 0.5 (0.1) (0.2) (0.0) (0.1) (0.1) (0.1) (0.0) 0 0 0 0 0
Total Stockholders' Equity 315.3 107.2 136.9 156.7 174.6 128.0 152.0 174.7 191.5 208.8 225.8 151.7 166.4 180.3 195.6 115.1 129.1 141.1 152.3 67.7 92.6 101.1 19.4
Total Liabilities & Equity 348.1 137.7 169.4 190.0 204.4 155.4 182.5 205.3 218.3 235.0 255.1 179.8 192.7 206.0 223.9 143.1 135.0 146.4 160.0 90.7 98.7 105.1 22.1
Debt Metrics
Total Debt 16.6 17.0 17.4 17.8 18.1 18.4 18.8 19.1 19.0 19.3 19.6 20.2 20.4 20.6 20.9 21.1 0.7 0.8 1.0 1.1 1.3 0.9 0.0
Net Debt (51.2) (67.8) (42.1) (29.8) (89.3) (19.8) (12.9) (6.3) (11.0) (7.0) (21.5) (35.4) (27.3) (17.9) (100.7) (40.0) (53.2) (107.6) (148.1) (80.7) (90.9) (98.8) (17.4)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (45.6) (33.7) (25.6) (26.1) (27.0) (27.5) (25.8) (21.0) (20.3) (19.7) (22.1) (18.5) (18.3) (17.5) (16.6) (15.9) (13.5) (12.8) (11.6) (8.8) (8.9) (5.9) (4.9) (3.6) (6.2) (7.5)
Depreciation & Amortization 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2
Stock-Based Compensation 12.4 3.8 3.3 3.7 3.8 3.5 2.9 2.8 3.1 2.9 2.6 2.3 1.9 1.9 1.8 1.7 1.3 1.6 1.3 0.6 0.3 0.2 0.2 0.2 0.2 0.2
Change in Working Capital 1.1 (0.4) 1.6 2.0 2.0 0.4 (0.9) 3.4 1.7 (6.8) 2.0 0.8 2.1 (0.5) (3.8) 3.3 1.1 (4.3) (2.0) (0.6) 1.8 0.4 0.7 (3.4) (0.7) (1.6)
Other Non-Cash Items 0.1 0.1 (0.0) 0.1 0.1 (0.1) (0.4) (0.7) (1.0) (1.2) 2.6 0.5 (0.7) (0.7) 0.2 (0.2) 0.1 0.0 0.0 (0.1) 0.1 (0.0) (0.0) 0.0 0.6 0.7
Operating Cash Flow (31.8) (29.9) (20.5) (20.1) (20.8) (23.4) (24.0) (15.3) (16.1) (24.5) (17.4) (15.4) (14.6) (16.4) (18.0) (10.8) (10.6) (15.2) (12.1) (8.7) (6.5) (5.1) (3.8) (6.6) (5.9) (8.1)
Investing Activities
Capital Expenditure (0.0) (0.1) (0.2) (0.0) (0.0) (0.2) (0.3) (0.3) (0.5) (0.1) (0.3) (0.1) (0.2) (0.1) (0.4) (0.1) (0.1) (0.6) (0.8) (0.6) (0.7) (0.1) (0.1) (0.1) (0.1) (0.5)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (256.0) 0 0 (74.0) (10.0) 0 (0.0) (20.0) (9.9) (29.2) (144.8) 0 0 (88.8) (48.5) 0 (46.4) (24.9) 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 30 55 30 30 30 30 30.0 30.2 30.3 38.7 55.0 21.7 21.6 22.1 32 18.0 3 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow (226.0) 54.9 29.8 (44.0) 20.0 29.8 29.7 9.9 19.8 9.4 (90.1) 21.6 21.4 (66.9) (16.9) 17.9 (43.4) (25.5) (0.8) (0.6) (0.7) (0.1) (0.1) (0.1) (0.1) (0.5)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased (39.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 241.8 0 0 1.1 0 0 0 0 0 0 0 0.3 0 0 8.5 0 0 0 (0.0) 0 0.0 (0.0) 0.1 (0.1) 0.1 0.0
Financing Cash Flow 461.7 0.3 2.8 4.4 69.9 0.1 0.5 0.7 0.1 0.3 93.0 1.6 2.5 0.2 95.2 0.1 0.3 0.0 80.1 (1.1) (0.3) 87.5 5.1 4.8 0.1 0.0
Cash Position
Net Change in Cash 203.7 25.3 12.0 (59.8) 69.1 6.5 6.3 (4.7) 3.8 (14.8) (14.5) 7.9 9.2 (83.1) 60.3 7.4 (54.5) (40.7) 67.2 (10.4) (7.4) 82.3 1.2 (1.9) (5.8) (8.5)
Cash at Beginning 84.8 59.5 48.3 108.1 39.0 32.5 26.2 30.8 26.3 41.1 55.6 48.5 38.5 122.4 62.1 53.9 108.4 149.1 81.8 92.2 99.8 17.5 16.2 18.2 24.0 32.5
Cash at End 288.5 84.8 60.3 48.3 108.1 39.0 32.5 26.2 30.1 26.3 41.1 56.4 47.8 39.3 122.4 61.3 53.9 108.4 149.1 81.8 92.4 99.8 17.5 16.2 18.2 24.0
Free Cash Flow (31.8) (30.0) (20.6) (20.2) (20.8) (23.5) (24.3) (15.6) (16.7) (24.5) (17.7) (15.5) (14.8) (16.5) (18.4) (10.8) (10.7) (15.8) (12.9) (9.3) (7.2) (5.2) (3.9) (6.7) (5.9) (8.6)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 (0.3) 0 0 0 0 (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (48.1) (34.9) (27.2) (27.9) (28.6) (29.0) (27.8) (23.2) (22.8) (22.3) (24.8) (20.5) (20.3) (19.4) (17.6) (16.1) (13.8) (12.8) (11.6) (8.9) (8.8) (5.9) (4.9) (3.6) (6.2) (7.5)
Net Income (45.6) (33.7) (25.6) (26.1) (27.0) (27.5) (25.8) (21.0) (20.3) (19.7) (22.1) (18.5) (18.3) (17.5) (16.6) (15.9) (13.5) (12.8) (11.6) (8.8) (8.9) (5.9) (4.9) (3.6) (8.1) (9.4)
EPS (Diluted) -0.48 -0.50 -0.40 -0.40 -0.47 -0.55 -0.52 -0.42 -0.41 -0.40 -0.50 -0.48 -0.48 -0.40 -1.31 -0.54 -0.46 -0.44 -0.42 -0.32 -0.45 -0.30 -0.25 -0.19 -0.22 -0.27
Balance Sheet
Cash & Equivalents 67.8 84.8 59.5 47.6 107.4 38.2 31.7 25.4 30.1 26.3 41.1 55.6 47.7 38.5 121.6 61.1 53.8 108.4 149.1 81.8 92.2 99.7 17.4
Total Assets 348.1 137.7 169.4 190.0 204.4 155.4 182.5 205.3 218.3 235.0 255.1 179.8 192.7 206.0 223.9 143.1 135.0 146.4 160.0 90.7 98.7 105.1 22.1
Total Debt 16.6 17.0 17.4 17.8 18.1 18.4 18.8 19.1 19.0 19.3 19.6 20.2 20.4 20.6 20.9 21.1 0.7 0.8 1.0 1.1 1.3 0.9 0.0
Stockholders' Equity 315.3 107.2 136.9 156.7 174.6 128.0 152.0 174.7 191.5 208.8 225.8 151.7 166.4 180.3 195.6 115.1 129.1 141.1 152.3 67.7 92.6 101.1 19.4
Cash Flow
Operating Cash Flow (31.8) (29.9) (20.5) (20.1) (20.8) (23.4) (24.0) (15.3) (16.1) (24.5) (17.4) (15.4) (14.6) (16.4) (18.0) (10.8) (10.6) (15.2) (12.1) (8.7) (6.5) (5.1) (3.8) (6.6) (5.9) (8.1)
Capital Expenditure (0.0) (0.1) (0.2) (0.0) (0.0) (0.2) (0.3) (0.3) (0.5) (0.1) (0.3) (0.1) (0.2) (0.1) (0.4) (0.1) (0.1) (0.6) (0.8) (0.6) (0.7) (0.1) (0.1) (0.1) (0.1) (0.5)
Free Cash Flow (31.8) (30.0) (20.6) (20.2) (20.8) (23.5) (24.3) (15.6) (16.7) (24.5) (17.7) (15.5) (14.8) (16.5) (18.4) (10.8) (10.7) (15.8) (12.9) (9.3) (7.2) (5.2) (3.9) (6.7) (5.9) (8.6)